$46.73 -1.37 (-2.85%)
7/2/2009 4:00 PM

Celgene Corp (CELG)

CAPS Rating: 4 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Current Price $46.73 Mkt Cap $22.14B
Open $0.00 P/E Ratio 55.29
Prev. Close $48.10 Div. (Yield) N/A (N/A)
Daily Range $46.50 - $47.59 Volume 0
52-Wk Range $36.90 - $77.39 Avg. Daily Vol. 0

CELG News and Articles

All stories about CELG

Caps

How do you think CELG will perform vs the S&P 500?

Add Stock to Watchlist

All Members

1,324 Outperform
56 Underperform
 

All-Star Members

395 Outperform
17 Underperform
 

Wall Street

22 Outperform
0 Underperform
 

Top CELG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.57)
Submitted February 27, 2009

Just as Obama enthusiasm for stem cell stocks is senseless, Obama pessimism for pharmaceuticals is overblown. I don't believe his policies will fundamentally change the business model or profitability of mid-to-large cap biotechs, and I see this as… More

1 Comment | Reply | Report this Post

NetscribeBiotech (< 20)
Submitted February 22, 2007

Celgene is a biopharmaceutical company focused on novel therapies to treat a broad range of hematopoietic, immunological, neuronal, and cancerous conditions. Celgene currently markets Thalomid for ENL and multiple myeloma, Revlimid for… More

1 Comment | Reply | Report this Post
CELG VS S&P 500 (SPY)

Fools bullish on CELG are also bullish on:

Fools bearish on CELG are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about CELG.

Recs

0
Member Avatar CramersSkeeDaddy (43.04) Submitted: 6/19/2009 3:42:26 PM : Outperform Start Price: $46.90 CELG Score: +2.09

per cramer

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar kropopkin (46.08) Submitted: 6/11/2009 8:33:38 AM : Outperform Start Price: $43.31 CELG Score: +12.94

Customised therapies are the future of medicines and diagnostics

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar MRSTARBUCKS (20.83) Submitted: 5/19/2009 4:44:05 PM : Outperform Start Price: $39.66 CELG Score: +19.49

GOOD BIOTECH

Report this Post 0 Comments | Reply | Permalink
View All 196 Pitches »

Leaderboard

Find the members with the highest scoring picks in CELG.

Score Leader

Roadkillguam

Roadkillguam (83.95) Score: +74.78

The Score Leader is the member with the highest score across all their picks in CELG.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
martyc484 < 20 9/15/2006 Outperform 3Y $40.70 +14.82% -32.34% +47.16 1 Comment
poang < 20 9/15/2006 Outperform 3Y $40.93 +14.17% -32.18% +46.35
predfern 36.54 9/15/2006 Outperform 5Y $40.93 +14.17% -32.18% +46.35 1 Comment
shanedawg 87.43 9/16/2006 Outperform 1Y $40.99 +14.00% -32.34% +46.34
nepedal 74.63 9/21/2006 Outperform 3Y $41.10 +13.70% -32.20% +45.89 1 Comment
MYSTICQUEEN 26.36 9/21/2006 Outperform 3Y $41.23 +13.34% -32.19% +45.53
pharmaway < 20 9/14/2006 5/6/2008 Outperform 1Y $41.10 +13.70% -31.79% +45.49 1 Comment
jolen168 < 20 9/14/2006 Outperform 3Y $41.17 +13.50% -31.94% +45.45
littleboyblue2 55.19 9/14/2006 Outperform 3M $41.17 +13.50% -31.94% +45.45
bronxboston 88.49 9/14/2006 Outperform 1Y $41.17 +13.50% -31.94% +45.45
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackMorganJos < 20 6/16/2009 Outperform NS $42.59 +9.72% -3.67% +13.39
TrackWedbush 86.01 3/20/2009 Outperform NS $45.98 +1.63% +15.84% -14.21
TrackOppenheimer 87.12 2/18/2009 Outperform NS $52.38 -10.79% +12.56% -23.34
TrackRBCCapMkts 88.51 2/4/2009 Outperform NS $53.18 -12.13% +6.54% -18.66
TrackZacks 75.50 2/2/2009 Outperform 3M $53.47 -20.87% +1.24% -22.11 4/6/2009 @ $42.31 1 Comment
TrackBarclaysCap 96.99 1/7/2009 Outperform NS $51.41 -9.10% -2.08% -7.02
TrackRWBaird 87.89 10/13/2008 Outperform NS $56.66 -4.61% -0.79% -3.81 1/6/2009 @ $54.05
TrackCowenandCo 78.61 10/8/2008 Outperform NS $54.69 -14.55% -7.75% -6.81
TrackCreditSuiss 89.18 7/25/2008 Outperform NS $74.45 -43.79% -30.88% -12.91 5/1/2009 @ $41.85
TrackPacificGrow 91.58 5/9/2008 Outperform NS $61.26 -23.72% -35.42% +11.70
TrackWachovia 75.72 12/4/2007 Outperform NS $60.12 -22.27% -38.76% +16.49
TrackBofASec 95.34 11/26/2007 Outperform NS $63.20 -26.06% -37.82% +11.76
TrackBMOCapital 87.19 11/20/2007 Outperform NS $64.87 -27.96% -37.68% +9.71
TrackSwensen 39.00 9/30/2007 Outperform NS $71.31 -34.47% -41.14% +6.67 1 Comment
TrackWMBlair 88.83 8/28/2007 Outperform NS $60.00 -22.12% -38.14% +16.02
TrackCowenandCo 78.61 8/8/2007 Outperform NS $61.84 -17.85% +1.70% -19.55 12/12/2007 @ $50.80
TrackJefferies 77.40 7/12/2007 Outperform NS $60.00 -22.12% -41.06% +18.94
TrackLehmanBros 80.65 6/26/2007 Outperform NS $57.26 -18.39% -40.21% +21.82
TrackCreditSuiss 89.18 5/11/2007 Outperform NS $63.32 -3.68% -7.34% +3.66 5/9/2008 @ $60.99
TrackPiperJaff 85.83 4/5/2007 Outperform NS $56.07 -16.66% -37.48% +20.82
TrackBernstein 82.50 3/13/2007 Outperform NS $51.37 -9.03% -36.11% +27.07
TrackUBS 86.07 2/21/2007 Outperform NS $53.70 -12.98% -38.32% +25.34
TrackRodmanRen 81.15 12/18/2006 Outperform NS $58.75 -20.46% -36.99% +16.53
TrackFBRCapitalM 79.95 12/11/2006 Outperform NS $56.69 +12.67% -9.70% +22.37 6/30/2008 @ $63.87
TrackLazardCapit 41.24 11/20/2006 Outperform NS $56.20 -16.85% -35.88% +19.03
TrackJMP 29.30 10/30/2006 Outperform NS $48.59 -3.83% -34.73% +30.91
TrackJimCramer 64.82 2/27/2006 Outperform 3W $38.45 +21.53% -30.85% +52.38

Featured Broker Partners